Загрузка...
Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life
Long-acting injectable antipsychotics (LAIs) were developed to make treatment easier, improve adherence, and/or signal the clinician when nonadherence occurs. Second-generation antipsychotic LAIs (SGA-LAIs) combine the advantages of SGA with a long-acting formulation. The purpose of this review is t...
Сохранить в:
| Опубликовано в: : | Neuropsychiatr Dis Treat |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4844443/ https://ncbi.nlm.nih.gov/pubmed/27143893 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S88632 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|